Jennifer Hassard

Ms. Hassard is an Investment Analyst for MDS Capital working in the Montreal office.
Ms. Hassard studied Human Genetics and Molecular Biology at McGill, where she completed a M.Sc.
Biology in the field of programmed cell death and cancer.
Her Master's research, carried out at the National Research Council's Biotechnology Research Centre, concentrated on mitochondrial proteomics and protein binding in anti-apoptotic signaling.
Ms. Hassard has consulting experience for the Quebec biotech industry and recently completed her M.B.A.
at HEC Montréal.